Search of: "Pinealoma" - List Results

Rank

Status

Study

Recruiting

Bone Marrow Radiation Therapy Followed by Busulfan, Melphalan, Thiotepa, and an Autologous Stem Cell Transplant in Treating Patients With High-Risk or Relapsed Solid Tumors

Conditions:

Brain and Central Nervous System Tumors; Kidney Cancer; Liver Cancer; Retinoblastoma; Sarcoma; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific

Interventions:

Drug: busulfan; Drug: etoposide; Drug: filgrastim; Drug: ifosfamide; Drug: melphalan; Drug: sargramostim; Drug: thiotepa; Procedure: autologous bone marrow transplantation; Procedure: autologous hematopoietic stem cell transplantation; Procedure: intensity-modulated radiation therapy; Procedure: peripheral blood stem cell transplantation; Procedure: pharmacological study; Procedure: positron emission tomography; Procedure: tomotherapy; Procedure: total marrow irradiation

Recruiting

Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment

Conditions:	Brain and Central Nervous System Tumors; Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific
Interventions:	Drug: bortezomib; Drug: temozolomide; Procedure: pharmacological study

Recruiting

Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors

Conditions:	Brain and Central Nervous System Tumors; Cancer-Related Problem/Condition; Fatigue
Interventions:	Drug: donepezil hydrochloride; Drug: placebo

Active, not recruiting

Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors

Conditions:	Brain and Central Nervous System Tumors; Unspecified Adult Solid Tumor, Protocol Specific
Interventions:	Drug: calcitriol; Drug: carboplatin

Recruiting

Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer

Conditions:	Brain and Central Nervous System Tumors; Cancer-Related Problem/Condition; Head and Neck Cancer; Sarcoma
Interventions:	Drug: bevacizumab; Drug: placebo

Recruiting

Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors

Conditions:	Brain and Central Nervous System Tumors; Cancer-Related Problem/Condition
Interventions:	Drug: levetiracetam; Drug: pregabalin

Active, not recruiting

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Condition:	Cancer
Interventions:	Drug: docetaxel; Drug: thalidomide

Recruiting

Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors

Conditions:	Brain and Central Nervous System Tumors; Cancer-Related Problem/Condition
Interventions:	Drug: temozolomide; Procedure: fertility assessment and management; Procedure: management of therapy complications

Recruiting

Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom

Conditions:	Bladder Cancer; Brain and Central Nervous System Tumors; Esophageal Cancer; Intraocular Melanoma; Kidney Cancer; Lymphoma; Melanoma (Skin); Pancreatic Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter
Interventions:	Procedure: DNA analysis; Procedure: laboratory biomarker analysis; Procedure: polymorphism analysis; Procedure: questionnaire administration

Recruiting

Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors

Conditions:	Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Kidney Cancer; Liver Cancer; Lymphoma; Neuroblastoma; Ovarian Cancer; Sarcoma; Testicular Germ Cell Tumor; Unspecified Childhood Solid Tumor, Protocol Specific
Interventions:	Drug: carboplatin; Drug: dasatinib; Drug: etoposide phosphate; Drug: ifosfamide; Procedure: gene expression profiling; Procedure: immunohistochemistry staining method; Procedure: laboratory biomarker analysis; Procedure: radiation therapy; Procedure: therapeutic conventional surgery; Procedure: western blotting

Suspended

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors

Conditions:	Brain and Central Nervous System Tumors; Neuroblastoma
Interventions:	Drug: astatine At 211 monoclonal antibody 81C6; Procedure: surgical procedure

Completed

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Condition:	Cancer
Intervention:	Drug: entinostat

Active, not recruiting

Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors

Conditions:	Brain and Central Nervous System Tumors; Neuroblastoma
Interventions:	Drug: carmustine; Drug: iodine I 131 monoclonal antibody 81C6; Drug: irinotecan hydrochloride; Procedure: surgical procedure

Recruiting

Collecting and Storing Information From Patients With Cancer or Other Chronic Disease Who Have Undergone Neurobehavioral Assessments on Another Clinical Trial

Conditions:	Brain and Central Nervous System Tumors; Cancer-Related Problem/Condition; Leukemia; Lymphoma; Neurofibromatosis Type 1 (nf1); Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
Interventions:	Procedure: cognitive assessment; Procedure: management of therapy complications; Procedure: physiologic testing; Procedure: psychosocial assessment and care; Procedure: quality-of-life assessment